P1NP & CTx Blood Tests: Bone Turnover Markers Explained

Let’s explore how your bone-building cells (osteoblasts) create bone markers we can measure. When these cells are working, they produce two types of substances:

1. Special enzymes and proteins that show osteoblast activity
2. Type 1 collagen, which we track through P1NP (marker of bone formation)

The collagen story is particularly fascinating. Think of building bone like crafting a rope:

• First, your body creates strands of collagen (called procollagen)
• Before these strands can be twisted together into their final form (the triple helix), they need trimming
• The trimmed pieces don’t go to waste – doctors can measure these fragments to understand how much new bone you’re building [1]

Understanding Your P1NP Lab Test Results

P1NP lab test results need to be interpreted in context, not in isolation.

Your P1NP bone marker level reflects how actively your osteoblasts are producing new bone. But a single reading is just a snapshot. What matters most is how your P1NP level compares to the reference range for your age and menopausal status, how it changes over time (especially before and after starting treatment), and how it relates to your CTx level, DEXA score, and clinical history.

Here is a general guide to help you understand what your P1NP lab test results may mean:

• If your P1NP is within the normal reference range (approximately 15–75 µg/L for adult women): Your bone formation activity is typical. If you are not on medication, this suggests your osteoblasts are working at a normal pace. If you are taking an antiresorptive medication like a bisphosphonate or Prolia, a P1NP in the lower half of the premenopausal reference range is generally the treatment target, it indicates the medication has slowed your overall bone turnover as intended.
• If your P1NP is above the reference range: In untreated patients, this may indicate high bone turnover, your body is actively building bone, but often because it is also actively breaking bone down. High P1NP in an untreated patient is not necessarily a positive sign, as rapid turnover can weaken bone microarchitecture. In patients taking bone-building (anabolic) medications like teriparatide (Forteo) or abaloparatide (Tymlos), an elevated P1NP is expected and desirable, it confirms the medication is stimulating new bone formation.
• If your P1NP is below the reference range: This may suggest that your osteoblasts are not building bone as actively as expected. If you are taking a bone-building medication and your P1NP remains low, it could indicate the treatment is not producing the desired response, and your doctor may need to adjust your plan.

Who Can Interpret Your Bone Marker Results?

Not all healthcare providers are experienced with bone turnover markers. If your primary care physician ordered the test but is unsure how to interpret the results, consider requesting a referral to a specialist with expertise in metabolic bone disease. The providers most likely to be comfortable interpreting P1NP and CTx results include:

• Endocrinologists — particularly those who specialize in osteoporosis and metabolic bone disorders
• Rheumatologists — like Dr. Silverman, many rheumatologists use bone markers routinely
• Metabolic bone disease clinics — some academic medical centers have dedicated osteoporosis or bone health clinics with physicians who specialize in this area

If you are having difficulty finding a specialist, the American Society for Bone and Mineral Research (ASBMR) maintains a clinician directory, and the National Osteoporosis Foundation (now part of the Bone Health & Osteoporosis Foundation) can help you locate specialists in your region.

It is also worth bringing a copy of all your bone marker results to each appointment, including the specific laboratory, assay used, and reference ranges printed on the lab report, so your doctor can make the most accurate comparisons over time.

How Often Should P1NP Be Tested?

The recommended frequency for P1NP lab testing depends on your treatment status and clinical situation:

• At the start of treatment: Your doctor should order a baseline P1NP lab test before you begin any new osteoporosis medication. This gives a starting point to measure your treatment response against.
• 3 to 6 months after starting medication: This is the critical first follow-up. For antiresorptive medications (bisphosphonates, Prolia), your doctor is looking for a decline in P1NP of approximately 30% or more from baseline — this indicates the medication is working. For anabolic medications (teriparatide, abaloparatide), the expectation is a significant rise in P1NP, often peaking around 3 to 6 months.
• Ongoing monitoring: Once your treatment response has been confirmed, many clinicians test bone markers once or twice per year. Dr. Silverman uses them at regular intervals to ensure continued medication effectiveness and to catch any changes early.
• During medication transitions: Bone marker testing becomes especially important when transitioning between treatments, for example, moving from Prolia to a bisphosphonate, or from an anabolic medication to an antiresorptive. During these transitions, your doctor may test more frequently (every 3 to 6 months) to ensure the new medication is maintaining your bone health.
• Insurance note: Traditional Medicare typically covers CTx testing once per year. Coverage for P1NP lab tests varies by insurer. Check with your insurance provider about the specific CPT codes (82523 for P1NP) and any frequency limitations before scheduling tests.